Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS' EQUITY (Tables)

v2.4.0.8
STOCKHOLDERS' EQUITY (Tables)
3 Months Ended
Sep. 30, 2013
Stockholders' Equity Note [Abstract]  
Warrant Activity and Related Balances Outstanding
Warrant activity during the three months ended September 30, 2013 and related balances outstanding as of such dates are reflected below:
 
 
 
Number
 
Weighted
Average
Exercise
Price Per
Share
 
Remaining
Contract
Term (#
years)
 
Shares purchasable under outstanding warrants at June 30, 2013
 
 
2,907,347
 
$
0.41
 
 
 
 
Stock purchase warrants issued
 
 
—
 
 
—
 
 
 
 
Stock purchase warrants exercised
 
 
—
 
 
—
 
 
 
 
Shares purchasable under outstanding warrants at September 30, 2013
 
 
2,907,347
 
$
0.41
 
 
3.71 - 4.09
 
 
Warrant activity during the three months ended September 30, 2012 and related balances outstanding as of such dates are reflected below:
 
 
 
Number
 
Weighted
Average
Exercise
Price Per
Share
 
Remaining
Contract
Term (#
years)
 
Shares purchasable under outstanding warrants at June 30, 2012
 
 
2,400,328
 
$
0.41
 
 
 
 
Stock purchase warrants issued
 
 
458,732
 
 
—
 
 
 
 
Stock purchase warrants exercised
 
 
—
 
 
—
 
 
 
 
Shares purchasable under outstanding warrants at September 30, 2012
 
 
2,859,060
 
$
0.41
 
 
4.74
 
Stock Option Activity
Activity in options during the three months ended September 30, 2013 and related balances outstanding as of that date are reflected below:
 
 
 
Number of
Shares
 
Weighted
Average
Exercise Price
 
Weighted
Average
Remaining
Contract
Term (# years)
 
Outstanding at June 30, 2013
 
 
2,527,389
 
$
0.15
 
 
 
 
Granted
 
 
3,010,973
 
 
 
 
 
 
 
Exercised
 
 
—
 
 
 
 
 
 
 
Forfeited and cancelled
 
 
—
 
 
 
 
 
 
 
Outstanding at September 30, 2013
 
 
5,538,362
 
$
0.12
 
 
8.23
 
Exercisable at September 30, 2013
 
 
3,635,462
 
$
0.19
 
 
7.49
 
 
Activity in options during the three months ended September 30, 2012 and related balances outstanding as of that date are reflected below:
 
 
 
Number of
Shares
 
Weighted
Average
Exercise Price
 
Weighted
Average
Remaining
Contract
Term (# years)
 
Outstanding at June 30, 2012
 
 
4,536,949
 
$
0.17
 
 
 
 
Granted
 
 
—
 
 
 
 
 
 
 
Exercised
 
 
(549,552)
 
 
 
 
 
 
 
Forfeited and cancelled
 
 
(1,460,009)
 
 
 
 
 
 
 
Outstanding at September 30, 2012
 
 
2,527,388
 
$
0.17
 
 
7.35
 
Exercisable at September 30, 2012
 
 
1,997,279
 
$
0.17
 
 
5.58
 
Employee Option Grants and Non-employee Option Grants
We allocated stock-based compensation expense included in the condensed consolidated statements of operations for employee option grants and non-employee option grants as follows:
 
Three months ended September 30,
 
2013
 
2012
 
Research and development
 
$
(1,000)
 
$
5,000
 
General and administration
 
 
24,000
 
 
40,000
 
Total stock-based compensation expense
 
$
23,000
 
$
45,000
 
Stock Options Valuation Assumptions
 The Company uses the Black-Scholes valuation model to calculate the fair value of stock options. The fair value of stock options was measured at the grant date using the assumptions (annualized percentages) in the table below:
 
Three months ended September 30,
 
2013
 
2012
 
Expected volatility
 
 
218%
 
 
100%
 
Risk free interest rate
 
 
1.4% to 1.7%
 
 
0.8% to 3.0%
 
Forfeiture rate
 
 
13%
 
 
5%
 
Dividend yield
 
 
0%
 
 
0%
 
Expected term
 
 
3-5 years
 
 
5-10 years